South Korea
· Delayed Price · Currency is KRW Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 222.33 billion. The enterprise value is 361.43 billion.
| Market Cap | 222.33B |
| Enterprise Value | 361.43B |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
KRX:009290 has 39.28 million shares outstanding. The number of shares has decreased by -0.98% in one year.
| Current Share Class | 39.28M |
| Shares Outstanding | 39.28M |
| Shares Change (YoY) | -0.98% |
| Shares Change (QoQ) | -1.45% |
| Owned by Insiders (%) | 12.95% |
| Owned by Institutions (%) | 26.95% |
| Float | 32.12M |
Valuation Ratios
The trailing PE ratio is 8.67.
| PE Ratio | 8.67 |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.97, with an EV/FCF ratio of -7.25.
| EV / Earnings | 13.89 |
| EV / Sales | 0.23 |
| EV / EBITDA | 12.97 |
| EV / EBIT | 27.74 |
| EV / FCF | -7.25 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.54 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 9.11 |
| Debt / FCF | -5.70 |
| Interest Coverage | 1.55 |
Financial Efficiency
Return on equity (ROE) is 4.51% and return on invested capital (ROIC) is 1.17%.
| Return on Equity (ROE) | 4.51% |
| Return on Assets (ROA) | 0.90% |
| Return on Invested Capital (ROIC) | 1.17% |
| Return on Capital Employed (ROCE) | 2.31% |
| Revenue Per Employee | 1.56B |
| Profits Per Employee | 25.22M |
| Employee Count | 1,032 |
| Asset Turnover | 1.42 |
| Inventory Turnover | 6.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.11% in the last 52 weeks. The beta is 0.46, so KRX:009290's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -14.11% |
| 50-Day Moving Average | 5,428.80 |
| 200-Day Moving Average | 5,639.40 |
| Relative Strength Index (RSI) | 66.36 |
| Average Volume (20 Days) | 27,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.61 trillion and earned 26.03 billion in profits. Earnings per share was 652.87.
| Revenue | 1.61T |
| Gross Profit | 283.57B |
| Operating Income | 16.38B |
| Pretax Income | 36.93B |
| Net Income | 26.03B |
| EBITDA | 31.22B |
| EBIT | 16.38B |
| Earnings Per Share (EPS) | 652.87 |
Balance Sheet
The company has 184.72 billion in cash and 284.35 billion in debt, giving a net cash position of -99.63 billion or -2,536.24 per share.
| Cash & Cash Equivalents | 184.72B |
| Total Debt | 284.35B |
| Net Cash | -99.63B |
| Net Cash Per Share | -2,536.24 |
| Equity (Book Value) | 616.72B |
| Book Value Per Share | 14,695.39 |
| Working Capital | 246.80B |
Cash Flow
In the last 12 months, operating cash flow was 28.13 billion and capital expenditures -77.98 billion, giving a free cash flow of -49.85 billion.
| Operating Cash Flow | 28.13B |
| Capital Expenditures | -77.98B |
| Free Cash Flow | -49.85B |
| FCF Per Share | -1,269.03 |
Margins
Gross margin is 17.66%, with operating and profit margins of 1.02% and 1.62%.
| Gross Margin | 17.66% |
| Operating Margin | 1.02% |
| Pretax Margin | 2.30% |
| Profit Margin | 1.62% |
| EBITDA Margin | 1.94% |
| EBIT Margin | 1.02% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 15.40% |
| Buyback Yield | 0.98% |
| Shareholder Yield | 2.74% |
| Earnings Yield | 11.71% |
| FCF Yield | -22.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
| Last Split Date | Apr 26, 1999 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.58 |
| Piotroski F-Score | n/a |